According to Gram Research analysis, Zadi-5, a traditional Mongolian medicine, reduced heart inflammation and improved heart function in mice with coronary heart disease by activating a protective protein called PPARG. In laboratory studies, the medicine suppressed harmful inflammatory responses and reduced heart tissue scarring. However, these findings come from animal studies only—human clinical trials are needed before Zadi-5 can be recommended as a heart disease treatment.

Researchers studied Zadi-5, a traditional Mongolian medicine, to understand how it might help people with heart disease. Using computer analysis and experiments with mice, scientists discovered that Zadi-5 contains compounds that can reduce inflammation and improve heart function. The medicine appears to work by activating a specific protein called PPARG that protects the heart. In mice with heart disease, Zadi-5 improved heart performance and reduced scarring and inflammation. While these results are promising, more human studies are needed before doctors can recommend it as a treatment.

Key Statistics

A 2026 research article published in Cardiology Research and Practice identified 250 active compounds in Zadi-5 that target heart disease pathways, with seven key proteins identified as primary therapeutic targets.

In mice with coronary heart disease, Zadi-5 treatment markedly enhanced heart performance while reducing fibrotic scarring and inflammatory responses compared to untreated controls.

Molecular docking analysis revealed strong binding affinities between PPARG, a heart-protective protein, and the main active components of Zadi-5, suggesting this is the primary mechanism of action.

The Quick Take

  • What they studied: Whether Zadi-5, a traditional Mongolian herbal medicine, could help treat coronary heart disease (a condition where blood vessels to the heart become blocked)
  • Who participated: Laboratory mice genetically modified to develop heart disease, plus computer analysis of human genetic data from heart disease patients
  • Key finding: Zadi-5 improved heart function in sick mice and reduced inflammation and scarring by activating a protective protein called PPARG
  • What it means for you: This research suggests Zadi-5 might one day help heart disease patients, but it’s still in early stages. Don’t use it instead of prescribed heart medications without talking to your doctor first

The Research Details

Scientists used two main approaches to study Zadi-5. First, they used computers to identify which active compounds (the healing ingredients) are in Zadi-5 and which human genes and proteins these compounds might affect. They compared this information against genes that are abnormal in heart disease patients.

Second, they tested Zadi-5 in real mice that had been genetically engineered to develop heart disease similar to humans. These mice were fed a high-fat diet to make their heart disease worse, then some received Zadi-5 while others didn’t. Researchers measured heart function, inflammation levels, and tissue damage in both groups.

The scientists also used a technique called molecular docking, which is like using a computer to predict how puzzle pieces fit together—in this case, how Zadi-5’s compounds fit into and activate specific proteins in the heart.

This combination of computer analysis and animal testing helps researchers understand not just whether something works, but how it works. This approach is important because it narrows down which compounds in the medicine are actually helpful and which proteins they target, making it more likely that future human studies will succeed.

The study used established scientific databases and published datasets, which adds credibility. The use of both computational and experimental methods strengthens the findings. However, the study was conducted only in mice, not humans, so results may not directly apply to people. The sample size of mice tested was not specified in the abstract, which limits our ability to assess statistical reliability.

What the Results Show

Researchers identified 250 different active compounds in Zadi-5 that could potentially affect the heart. When they compared these compounds to genes involved in heart disease, they found seven key proteins that Zadi-5 appears to target. The most important protein was PPARG, which is known to protect the heart from damage.

In mice with heart disease, Zadi-5 treatment significantly improved how well the heart pumped blood. The medicine also reduced two major problems in diseased hearts: fibrosis (scarring and stiffening of heart tissue) and inflammation (swelling and immune system activation that damages the heart).

At the molecular level, Zadi-5 suppressed a harmful protein called HIF-1α that increases during heart damage, while boosting PPARG levels. This suggests the medicine works by shifting the heart’s cellular environment from a damaging state to a protective state.

The computer analysis identified several other proteins that Zadi-5 might affect, including MPO, IFNG, TOP2A, PTGS2, CYP2J2, and F7. These proteins are involved in inflammation, immune response, and blood clotting—all important factors in heart disease. The molecular docking predictions showed that multiple active compounds in Zadi-5 could bind strongly to PPARG, suggesting the medicine’s effects aren’t due to just one ingredient but rather a combination of compounds working together.

This research builds on growing interest in traditional medicines for heart disease. Previous studies have shown that PPARG activation can protect the heart, and several approved heart medications work partly through this mechanism. The finding that a traditional medicine contains multiple compounds targeting the same protective pathway aligns with how many herbal medicines are believed to work—through multiple ingredients having complementary effects rather than a single active ingredient.

The biggest limitation is that this study was done in mice, not humans. Mice models don’t always predict how treatments will work in people. The study didn’t specify how many mice were tested or provide detailed statistical analysis of the results. The research also didn’t compare Zadi-5 to existing heart disease medications, so we don’t know if it’s better, worse, or similar to current treatments. Finally, the study didn’t test whether Zadi-5 is safe in humans or identify potential side effects.

The Bottom Line

Based on this research, Zadi-5 shows promise as a potential heart disease treatment, but confidence is moderate because results are from animal studies only. Do not use Zadi-5 as a replacement for prescribed heart medications. If you’re interested in traditional medicines for heart health, discuss options with your cardiologist. More human clinical trials are needed before any recommendations can be made.

People with coronary heart disease or at high risk for it should be aware of this research, but it’s not ready for clinical use yet. Researchers studying traditional medicines and heart disease will find this work valuable. Patients interested in complementary approaches should use this as information for conversations with their doctors, not as a reason to change their current treatment.

This research is in the early discovery phase. Typically, 5-10 years of additional research (including human safety studies and clinical trials) would be needed before Zadi-5 could potentially be approved as a heart disease treatment. Don’t expect this medicine to be available as a standard treatment in the near future.

Frequently Asked Questions

Can I use Zadi-5 to treat my heart disease instead of my current medications?

No. Zadi-5 has only been tested in mice, not humans. Continue taking prescribed heart medications as directed by your cardiologist. Discuss any interest in traditional medicines with your doctor before making any changes to your treatment plan.

How does Zadi-5 work to protect the heart?

Research suggests Zadi-5 works by activating a protein called PPARG that reduces inflammation and prevents heart tissue scarring. It also suppresses HIF-1α, a harmful protein that increases during heart damage, shifting the heart toward a protective state.

When will Zadi-5 be available as a heart disease treatment?

This research is in early discovery stages. Typically 5-10 years of additional studies, including human safety trials and clinical effectiveness studies, would be needed before any traditional medicine could be approved for treating heart disease.

Is Zadi-5 safe for humans?

This study didn’t test Zadi-5 in humans or identify safety concerns. Before any human use, researchers must conduct safety studies to determine appropriate doses and identify potential side effects or drug interactions.

How does Zadi-5 compare to existing heart disease medications?

This study didn’t compare Zadi-5 to current heart medications, so we don’t know if it’s more or less effective. The research only shows it worked in mice with heart disease, not how it compares to proven treatments.

Want to Apply This Research?

  • Track heart health markers that would be relevant if Zadi-5 becomes available: resting heart rate, blood pressure readings, and any chest discomfort episodes. Record these weekly to establish baseline measurements and monitor changes over time.
  • Use the app to set reminders for proven heart-healthy habits while waiting for more research: take prescribed medications on schedule, exercise 30 minutes daily, reduce sodium intake, and track stress levels. These evidence-based changes work now while researchers continue studying Zadi-5.
  • Create a long-term health dashboard tracking cardiovascular risk factors: cholesterol levels, blood pressure, weight, and exercise frequency. This establishes your baseline and helps you and your doctor evaluate whether any future treatments (including Zadi-5 if approved) are actually helping.

This article describes early-stage research on Zadi-5 conducted in laboratory mice. These findings have not been tested in humans and should not be used to guide treatment decisions. If you have coronary heart disease or heart disease risk factors, consult your cardiologist before considering any new treatments, including traditional medicines. Do not discontinue or replace prescribed heart medications without explicit approval from your healthcare provider. This research is informational only and does not constitute medical advice.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: Integrated Network Pharmacology Analysis and Experimental Validation of Zadi-5 Against Coronary Heart Disease.Cardiology research and practice (2026). PubMed 42416519 | DOI